Abcam plc Рыночная капитализация
Что обозначает Рыночная капитализация в Abcam plc?
Рыночная капитализация Abcam plc является $3.56B
Какое определение для Рыночная капитализация?
Рыночная капитализация - это рыночная стоимость в тот момент времени, когда акции, находящиеся в обращении публичной компании, равна цене акций в тот отрезок времени, умноженной на количество акций в обращении .
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Рыночная капитализация компаний в Health Care сектор на LSE по сравнению с Abcam plc
Что делает Abcam plc?
Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; cell line and lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. It also sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
Компании с рыночная капитализация похож на Abcam plc
- Eastern Bankshares имеет Рыночная капитализация из $3.55B
- NEPI Rockcastle plc имеет Рыночная капитализация из $3.55B
- The a2 Milk имеет Рыночная капитализация из $3.55B
- NantKwest Inc имеет Рыночная капитализация из $3.55B
- Alliance Trust PLC имеет Рыночная капитализация из $3.56B
- Angang Steel имеет Рыночная капитализация из $3.56B
- Abcam plc имеет Рыночная капитализация из $3.56B
- Melexis NV имеет Рыночная капитализация из $3.56B
- Spire имеет Рыночная капитализация из $3.56B
- The Renewables Infrastructure имеет Рыночная капитализация из $3.57B
- TAL Education имеет Рыночная капитализация из $3.57B
- Onto Innovation имеет Рыночная капитализация из $3.57B
- Bharat Heavy Electricals имеет Рыночная капитализация из $3.57B